These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Screening for Down syndrome. Lancet; 1987 Nov; 2(8567):1083-4. PubMed ID: 2444843 [No Abstract] [Full Text] [Related]
3. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852 [TBL] [Abstract][Full Text] [Related]
4. Screening for Down's syndrome. N Engl J Med; 1988 Apr; 318(14):926-9. PubMed ID: 2451130 [No Abstract] [Full Text] [Related]
6. Prenatal diagnosis--when and how? Platt LD; Carlson DE N Engl J Med; 1992 Aug; 327(9):636-8. PubMed ID: 1386407 [No Abstract] [Full Text] [Related]
7. The antenatal diagnosis of congenital disease. Gardner HA; Miskin M Otolaryngol Clin North Am; 1981 Feb; 14(1):47-57. PubMed ID: 6454874 [No Abstract] [Full Text] [Related]
8. [Controversy: systemic amniocentesis for women 38 years and more? Is it not premature to no longer accept performing amniocentesis on a patient age 38 years or more?]. Sagot P Gynecol Obstet Fertil; 2000 Oct; 28(10):769-71. PubMed ID: 11270348 [No Abstract] [Full Text] [Related]
9. Foetal medicine. Bearn AG Trans Med Soc Lond; 1973; 89():160-3. PubMed ID: 4282186 [No Abstract] [Full Text] [Related]
10. [Controversy: systemic amniocentesis for women 38 years and more? Is it still lawful to recommend amniocentesis with the sole criterion being maternal age of 38 years or more?]. Bernard JP Gynecol Obstet Fertil; 2000 Oct; 28(10):765-9. PubMed ID: 11244641 [No Abstract] [Full Text] [Related]
11. Prenatal screening for Down syndrome. Ogle RF; Chitty LS Hosp Med; 1998 Aug; 59(8):632-6. PubMed ID: 9829057 [TBL] [Abstract][Full Text] [Related]
12. [Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome]. Bessho T; Kanazawa R; Shiotani T; Mitsuo M; Koyama K Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar; 47(3):237-43. PubMed ID: 7535328 [TBL] [Abstract][Full Text] [Related]
13. Intrauterine diagnosis of congenital and genetic abnormalities. Cortner JA J Ark Med Soc; 1972 Nov; 69(6):178-81. PubMed ID: 4263777 [No Abstract] [Full Text] [Related]
16. Fear of pregnancy loss and fetal karyotyping: a place for third-trimester amniocentesis? Picone O; Senat MV; Rosenblatt J; Audibert F; Tachdjian G; Frydman R Fetal Diagn Ther; 2008; 23(1):30-5. PubMed ID: 17934295 [TBL] [Abstract][Full Text] [Related]
17. Prenatal cytogenetic diagnosis: first 1,000 successful cases. Hsu LY; Kaffe S; Yahr F; Serotkin A; Giordano F; Godmilow L; Kim HJ; David K; Kerenyi T; Hirschhorn K Am J Med Genet; 1978; 2(4):365-83. PubMed ID: 162527 [TBL] [Abstract][Full Text] [Related]
18. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909 [TBL] [Abstract][Full Text] [Related]
19. Reproductive outcome following amniocentesis for genetic indications. Porreco RP; Young PE; Resnik R; Cousins L; Jones OW; Richards T; Kernahan C; Matson M Am J Obstet Gynecol; 1982 Jul; 143(6):653-60. PubMed ID: 7091237 [No Abstract] [Full Text] [Related]
20. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]